Frontiers in Medicine · Oct 30, 2026

The impact of α-Lactalbumin supplementation on sleep quality: a systematic review and meta-analysis

By Quanpu Liu, Huazhong Xiong, Yuqing Shi et al.

Backgroundα-Lactalbumin (α-LA) is rich in tryptophan and may theoretically improve sleep by increasing central serotonin and melatonin levels. However, findings from randomized controlled trials (RCTs) remain inconsistent.MethodsPubMed, Web of Science, Embase, the Cochrane Library, China National Knowledge Infrastructure, and other relevant databases were systematically searched for RCTs comparing the effects of α-LA supplementation with placebo on sleep quality. We used a generic inverse-variance random-effects model to pool mean differences (MDs) with their 95% confidence intervals (CIs), accounting for within-participant correlation in crossover trials. Subgroup analyses were performed according to reported sleep-related recruitment criteria.ResultsSix publications comprising seven RCTs and 96 participants were included. Overall, the pooled MDs were −0.35 percentage points for sleep efficiency (SE; 95% CI: −1.25 to 0.54; p = 0.44; I2 = 18%), 2.35 min for total sleep time (TST; 95% CI: −8.44 to 13.14; p = 0.67; I2 = 46%), and −0.55 min for sleep onset latency (SOL; 95% CI: −2.98 to 1.87; p = 0.66; I2 = 0%). However, wake after sleep onset (WASO) showed a small pooled increase (MD = 2.71 min, 95% CI: 0.05 to 5.37; p = 0.05; I2 = 0%). Sleep structure outcomes were summarized narratively.ConclusionEvidence does not establish a consistent effect of bedtime α-LA supplementation on adult sleep quality or macrostructural sleep outcomes. The pooled analyses showed no statistically significant differences in TST, SE, or SOL. However, a small increase in WASO was observed (MD = 2.71 min, 95% CI: 0.05 to 5.37; p = 0.05), although its statistical significance was not maintained in some leave-one-out analyses. Individual studies suggested potential effects on NREM sleep architecture, but the available evidence remains limited.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/, PROSPERO CRD420261334405.

doi.org/10.3389/fmed.2026.1880738Open accessInterventions

AgingResearch.News